Interactive Study to Increase Glaucoma Adherence to Treatment

I-SIGHT: Interactive Study to Increase Glaucoma adHerence to Treatment Phase 2: Participant Recruitment & Intervention Delivery and Evaluation

Study participants who receive the I-SIGHT intervention will have higher rates of glaucoma treatment compliance (e.g., medication-taking and refill compliance, return for clinical follow-up) and more positive eye health outcomes at 12-month follow-up than participants who receive the control group intervention.

The intervention is telephone-based and individually-tailored to participants' compliance knowledge, attitudes, and behaviors; psychosocial predictors of compliance; health literacy; race and culture; and prescribed medication regimen. The intervention calls utilize interactive voice recognition technology to facilitate interest, participation, and interaction with call recipients. We evaluated the intervention in a randomized controlled trial with telephone interviews administered to all participants at baseline, 6, 9, and 12-months

Inclusion Criteria:

• Receive treatment at the Atlanta VA Medical Center or Grady Eye clinic for their eye condition
• Be between the ages of 18-80
• Be Caucasian or African American
• Possess a telephone (home telephone or cellular phone)
• Speak and understand English
• Be diagnosed with open angle glaucoma, be glaucoma suspect, or be ocular hypertensive for at least one year
• Be prescribed daily doses of topical treatments for at least one year
• Be able to read or have someone who can help the participant with reading written materials that we give to the participant

Exclusion Criteria:

• Having eye surgery within 3 months of baseline interview and enrollment
• Being legally blind (20/200 or worse)